A mouse model of ovarian cancer has shown a COX-2 gene dosage effect in promoting tumour development, and interestingly they showed that COX-2 may be important for tumour initiation whereas progression and malignancy is driven by COX-1 (35). Here, PTGS2 is linked to ovarian carcinoma.